全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 112811-65-1 | 2,4,5-Trifluoro-3-methoxybenzoic acid | C8H5F3O3 |
| 112811-66-2 | 2,4,5-Trifluoro-3-methoxybenzoyl chloride | C8H4ClF3O2 |
| 112811-70-8 | Ethyl 2-(2,4,5-trifluoro-3-methoxybenzoyl)-3-cyclopropylaminoacrylate | C16H16F3NO4 |
| 112811-71-9 | 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester | C16H15F2NO4 |
| 112811-72-0 | 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid | C14H11F2NO4 |
| 112811-90-2 | 2-Thiobenzyl nicotinic acid;2-[(Phenylmethyl)thio]-3-pyridinecarboxylic acid | C13H11NO2S |
| 112822-85-2 | 2,4,5-Trifluoro-3-methylbenzoic acid;3-Methyl-2,4,5-trifluorobenzoic acid | C8H5F3O2 |
| 112827-99-3 | 24R-Calcipotriol;(1alpha,3beta,5Z,7E,22E,24R)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1,3,24-triol; PRI 2202 | C27H40O3 |
| 112828-00-9 | Calcipotriol;Calcipotriene; (1R,3S,5Z)-5-[(2E)-2-[1-[(E,2R,5R)-5-Cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | C27H40O3 |
| 112830-95-2 | (6aR,10aR)-3-(1,1-Dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol;HU-210 | C25H38O3 |
| 112839-95-9 | (S)-3-Aminooxetan-2-one 4-methylbenzenesulfonate | C3H5NO2.C7H8O3S |
| 112849-17-9 | (2E,4R)-4-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-Bis[[(tert-butyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1H-inden-1-yl]-1-cyclopropyl-2-penten-1-one;(1a,3b,5E,7E,22E)-24-Cyclopropyl-1,3-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-9,10-secochola-5,7,10(19),22-tetraen-24-one | C39H66O3Si2 |
| 112849-27-1 | Bis-TBDMS-trans-calcipotriol;24-Cycloproyply-1,3-bis[[(1,1-dimethylethyl)dimethylsily]oxy]-9,10-secochola-5,7,10(19),22-tetraen-24-ol | C39H68O3Si2 |
| 112881-51-3 | 4'-(4-Pyridyl)-2,2':6',2''-terpyridine | C20H14N4 |
| 112883-29-1 | (R)-N-Fmoc-D-tyrosine;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-tyrosine | C24H21NO5 |
| 112883-39-3 | Fmoc-D-Aspartic acid beta-tert-butyl ester;N-(9-Fluorenylmethyloxycarbonyl)-D-aspartic acid 4-tert-butyl ester; Fmoc-D-Asp(OtBu)-OH | C23H25NO6 |
| 112883-40-6 | Fmoc-D-methionine;N-(9-Fluorenylmethyloxycarbonyl)-D-methionine; Fmoc-Met-OH | C20H21NO4S |
| 112883-41-7 | Fmoc-D-Norleucine;Fmoc-D-Nle-OH | C21H23NO4 |
| 112883-42-8 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-norleucine | C22H25NO4 |
| 112883-43-9 | (S)-N-Fmoc-3-(2-naphthyl)alanine;Fmoc-3-(2-Naphthyl)-L-alanine; N-(9-Fluorenylmethoxycarbonyl)-2-naphthyl-L-alanine | C28H23NO4 |
| 112885-41-3 | Mosapride;4-Amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide | C21H25ClFN3O3 |
| 112885-42-4 | Mosapride citrate ;4-Amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]-2-morpholinyl]methyl]-benzamide 2-hydroxy-1,2,3-propanetricarboxylate; Gasmotin | C21H25ClFN3O3.C6H8O7;C27H33ClFN3O10 |
| 112887-25-9 | 2-Fluoro-5-sulfamoylbenzoic acid | C7H6FNO4S |
| 112887-68-0 | Raltitrexed;(S)-2-[(1-{5-[Methyl-(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-amino]-thiophen-2-yl}-methanoyl)-amino]-pentanedioic acid | C21H22N4O6S |
| 112888-43-4 | 6-Bromomethyl-3,4-dihydro-2-methyl-quinazolin-4-one | C10H9BrN2O |
| 112889-02-8 | Diethyl N-[5-methylamino-2-thenoyl]-L-glutamate;N-[[5-(Methylamino)-2-thienyl]carbonyl]-L-glutamic acid diethyl ester | C15H22N2O5S |
| 112892-88-3 | 4-Carboxaldehydebenzocyclobutene | C9H8O |
| 112897-97-9 | trans-3,4-Difluorocinnamic acid | C9H6F2O2 |
| 112898-00-7 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-glutamine | C20H20N2O5 |
| 112898-15-4 | Adenosine 5'-(tetrahydrogen triphosphate) 3'-(4-benzoylbenzoate) compd. with N,N-diethylethanamine | C24H24N5O15P3.C6H15N |
| 112898-18-7 | Boc-D-aspartic acid 4-cyclohexyl ester;N-tert-Butyloxycarbonyl-D-aspartic acid 4-cyslohexyl ester | C15H25NO6 |
| 112898-23-4 | N-[(1,1-Dimethylethoxy)carbonyl]-3-(methylthio)-L-valine dicyclohexylammonium salt | C12H23N.C11H21NO4S |
| 112898-33-6 | 2,5-Difluorocinnamic acid;trans-2,5-Difluorocinnamic acid | C9H6F2O2 |
| 112901-68-5 | Anifostine trihydrate;2-(3-Aminopropylamino)ethylsulfanylphosphonic acid trihydrate | C5H15N2O3PS.3(H2O) |
| 112904-73-1 | 3,4-Dihydro-8-methoxy-2H-1-benzopyran-3-amine | C10H13NO2 |
| 112913-63-0 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-tryptophan | C27H24N2O4 |
| 112913-94-7 | 2-Acetylamidomethyl-4-(4-fluorobenzyl)morpholine | C14H19FN2O2 |
| 112914-13-3 | 2-Aminomethy-4-(4-fluorobenzyl)morpholine;4-[(4-Fluorophenyl)methyl]-2-morpholinemethanamine | C12H17FN2O |
| 112918-82-8 | N-(9-Fluorenylmethoxycarbonyl)iminodiacetic acid | C19H17NO6 |
| 112924-45-5 | Dexanabinol;1,1-Dimethylheptyl-11-hydroxytetrahydrocannabinol | C25H38O3 |
| 112926-00-8 | Silica gel;dioxosilane | SiO2 |
| 112926-02-0 | Indo 1-AM;2-[4-[Bis[2-[(acetyloxy)methoxy]-2-oxoethyl]amino]-3-[2-[2-[bis[2-[(acetyloxy)methoxy]-2-oxoetyl]amino]-5-methylphenoxy]ethoxy]phenyl]-1H-indole-6-carboxylic acid (acetyloxy)methyl ester | C47H51N3O22 |
| 112930-39-9 | 3-Bromo-5-isopropylbenzoic acid;3-Bromo-5-(1-methylethyl)benzoic acid | C10H11BrO2 |
| 112941-26-1 | o-Carbomethoxybenzyl sulfonamide;Methyl 2-[(sulfamoyl)methyl]benzoate | C9H11NO4S |
| 112941-35-2 | 2-(Trifluoromethyl)benzylsulfonamide | C8H8F3NO2S |
| 112945-52-5 | Silicon dioxide;dioxosilane; Fumed Silicas; Silica gel | SiO2 |
| 112955-03-0 | 3-Ethyl-8-methoxyquinoline | C12H13NO |
| 112955-31-4 | Human parathormone-related peptide(1-34)amide;1-34-Human PTHrP amide; 1-34-Human parathyroid hormone-related protein-NH2; Human PTHrP-(1-34)NH2 | C180H288N58O47 |
| 112960-16-4 | trans-3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol hydrochloride | C14H19NO3.HCl |
| 112965-21-6 | Calcipotriene;(1S,3S,5Z)-5-[(2E)-2-[(1R,3aR,7aR)-1-[(E,2S)-5-Cyclopropyl-5-hydroxy-pent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol | C27H40O3 |